Phio Pharmaceuticals Future Growth
How is Phio Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score
5/6Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
211.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 75 | 44 | N/A | N/A | 1 |
9/30/2022 | N/A | -12 | -12 | -12 | N/A |
6/30/2022 | N/A | -12 | -11 | -11 | N/A |
3/31/2022 | N/A | -13 | -12 | -12 | N/A |
12/31/2021 | N/A | -13 | -12 | -12 | N/A |
9/30/2021 | N/A | -12 | -12 | -12 | N/A |
6/30/2021 | N/A | -11 | -11 | -11 | N/A |
3/31/2021 | N/A | -10 | -10 | -10 | N/A |
12/31/2020 | N/A | -9 | -9 | -9 | N/A |
9/30/2020 | N/A | -9 | -9 | -9 | N/A |
6/30/2020 | N/A | -9 | -9 | -9 | N/A |
3/31/2020 | N/A | -9 | -9 | -9 | N/A |
12/31/2019 | 0 | -9 | -9 | -9 | N/A |
9/30/2019 | 0 | -8 | -8 | -8 | N/A |
6/30/2019 | 0 | -7 | -8 | -8 | N/A |
3/31/2019 | 0 | -7 | -8 | -8 | N/A |
12/31/2018 | 0 | -7 | -8 | -8 | N/A |
9/30/2018 | 0 | -8 | -8 | -8 | N/A |
6/30/2018 | 0 | -9 | -8 | -8 | N/A |
3/31/2018 | 0 | -9 | -9 | -9 | N/A |
12/31/2017 | 0 | -12 | -10 | -10 | N/A |
9/30/2017 | N/A | -15 | -9 | -9 | N/A |
6/30/2017 | N/A | -15 | -8 | -8 | N/A |
3/31/2017 | 0 | -14 | -8 | -8 | N/A |
12/31/2016 | 0 | -11 | -8 | -8 | N/A |
9/30/2016 | 0 | -9 | -8 | -8 | N/A |
6/30/2016 | 0 | -10 | N/A | -8 | N/A |
3/31/2016 | 0 | -10 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHIO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: PHIO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PHIO is expected to become profitable in the next 3 years.
Revenue vs Market: PHIO's revenue (256.9% per year) is forecast to grow faster than the US market (7.1% per year).
High Growth Revenue: PHIO's revenue (256.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PHIO's Return on Equity is forecast to be high in 3 years time